Sign Up to like & get
recommendations!
1
Published in 2021 at "Environmental toxicology"
DOI: 10.1002/tox.23372
Abstract: Tumor necrosis factor-related apoptosis-induced ligand (TRAIL) shows little or no toxicity in most normal cells and preferentially induces apoptosis in a variety of malignant cells. However, patients develop resistance to TRAIL, therefore, sensitizing agents that…
read more here.
Keywords:
chop;
csc 3436;
cells trail;
apoptosis ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Molecular and Cellular Biochemistry"
DOI: 10.1007/s11010-017-2997-x
Abstract: Malignant glioma is the most common and aggressive form of brain tumor with poor prognosis of survival. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising anticancer agent but is insufficient of inducing apoptosis in…
read more here.
Keywords:
mcl;
apoptosis;
bim bak;
glioma cells ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Anti-Cancer Drugs"
DOI: 10.1097/cad.0000000000000502
Abstract: Past reports have shown that the sensitivity of cancer cells to TRAIL-induced apoptosis is related to their expression of TRAIL-death receptors on the cell surface. However, the level of TRAIL-death receptors expression on cancer cells…
read more here.
Keywords:
trail;
induced apoptosis;
npc cells;
cells trail ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Molecular Cancer Therapeutics"
DOI: 10.1158/1535-7163.mct-20-0495
Abstract: Docetaxel and cabazitaxel are guideline-chemotherapy treatments for metastatic castration-resistant prostate cancer (mCRPC), which comprises the majority of prostate cancer deaths. TNF-related apoptosis inducing ligand (TRAIL) is an anticancer agent that is selectively cytotoxic to cancer…
read more here.
Keywords:
cells trail;
cancer cells;
cancer;
prostate cancer ... See more keywords